| Literature DB >> 28128970 |
Claus F Vogelmeier1, Gerard J Criner2, Fernando J Martinez3, Antonio Anzueto4,5, Peter J Barnes6, Jean Bourbeau7, Bartolome R Celli8, Rongchang Chen9, Marc Decramer10, Leonardo M Fabbri11, Peter Frith12, David M G Halpin13, M Victorina López Varela14, Masaharu Nishimura15, Nicolas Roche16, Roberto Rodriguez-Roisin17, Don D Sin18, Dave Singh19, Robert Stockley20, Jørgen Vestbo19, Jadwiga A Wedzicha6, Alvar Agustí21.
Abstract
This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 report focuses primarily on the revised and novel parts of the document. The most significant changes include: (1) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (2) for each of the groups A to D, escalation strategies for pharmacologic treatments are proposed; (3) the concept of deescalation of therapy is introduced in the treatment assessment scheme; (4) nonpharmacologic therapies are comprehensively presented; and (5) the importance of comorbid conditions in managing chronic obstructive pulmonary disease is reviewed.Entities:
Keywords: COPD diagnosis; COPD management; COPD prevention; chronic obstructive pulmonary disease
Mesh：
Substances：
Year: 2017 PMID： 28128970 DOI： 10.1164/rccm.201701-0218PP
Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405